Krystal Biotech Inc
NASDAQ:KRYS

Watchlist Manager
Krystal Biotech Inc Logo
Krystal Biotech Inc
NASDAQ:KRYS
Watchlist
Price: 132.03 USD 0.86% Market Closed
Market Cap: 3.8B USD

Intrinsic Value

The intrinsic value of one KRYS stock under the Base Case scenario is 201.13 USD. Compared to the current market price of 132.03 USD, Krystal Biotech Inc is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

KRYS Intrinsic Value
201.13 USD
Undervaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Krystal Biotech Inc

Valuation History Unavailable

Historical valuation for KRYS cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KRYS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Krystal Biotech Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Krystal Biotech Inc

Current Assets 766.8m
Cash & Short-Term Investments 616.8m
Receivables 103.3m
Other Current Assets 46.7m
Non-Current Assets 307.6m
Long-Term Investments 148.5m
PP&E 158.9m
Other Non-Current Assets 218k
Efficiency

Free Cash Flow Analysis
Krystal Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Krystal Biotech Inc

Revenue
333.4m USD
Cost of Revenue
-22.7m USD
Gross Profit
310.8m USD
Operating Expenses
-177.2m USD
Operating Income
133.6m USD
Other Expenses
-9.6m USD
Net Income
124m USD
Fundamental Scores

KRYS Profitability Score
Profitability Due Diligence

Krystal Biotech Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
ROE is Increasing
43/100
Profitability
Score

Krystal Biotech Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

KRYS Solvency Score
Solvency Due Diligence

Krystal Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Krystal Biotech Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

KRYS Price Targets Summary
Krystal Biotech Inc

Wall Street analysts forecast KRYS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for KRYS is 209.3 USD with a low forecast of 156.55 USD and a high forecast of 257.25 USD.

Lowest
Price Target
156.55 USD
19% Upside
Average
Price Target
209.3 USD
59% Upside
Highest
Price Target
257.25 USD
95% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Krystal Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for KRYS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

KRYS Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one KRYS stock?

The intrinsic value of one KRYS stock under the Base Case scenario is 201.13 USD.

Is KRYS stock undervalued or overvalued?

Compared to the current market price of 132.03 USD, Krystal Biotech Inc is Undervalued by 34%.

Back to Top